B. Metzler Seel. Sohn & Co. Holding Ag Cytokinetics Inc Call Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
409Shares Held
128MCall Options Held
3.39MPut Options Held
2.14M-
Black Rock Inc. New York, NY14.7MShares$824 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$661 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$457 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$422 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$368 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.29B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...